between national culture and EQ-5D value sets. Method Rank correlation analysis is used to explore relationships between the relative values of a set of EQ-5D states and dimensions of national culture. The latter are taken from Hofstede's framework which operationalizes national culture in 5 dimensions. The analysis is carried out using data from the countries for which EQ-5D value sets and scores on Hofstede's dimensions of culture both exist: Argentina, Denmark, Germany, Japan, Korea, The Netherlands, Poland, Spain, UK, USA. Results Some relationships among the EQ-5D dimensions and culture are observed. Eg. the culture dimension: Power-Distance correlates strongly with the EQ-5D dimension: Anxiety-Depression (Spearman's Rho for PowerDistance indices and TTO valuations of EQ-5D states 11112 and 11113 are 0.523 and 0.815 respectively). Strong and moderate relationships are observed among other culture dimensions (Individualism, Masculinity, Uncertainty-Avoidance) and EQ-5D dimensions (Pain, Self-Care). Discussion Different cultures appear to value EQ-5D dimensions differently. The correlation patterns observed in this study are generally consistent with a priori expectations based on the nature of the dimensions of culture and the EQ-5D model. This analysis demonstrates the potential of national culture in providing insight into the drivers of the relative values of EQ-5D dimensions for different countries, and in informing decisions about which EQ-5D value sets to use in situations where one does not exist.
1
University of Georgia, Athens, GA, USA, 2 McMaster University, Hamilton, ON, Canada OBJECTIVES Primary study objective was to test whether individuals' responses to standard gamble (SG) questions do not depend on the duration of time spent in the health scenario presented ("timelessness"). Secondary objective of the study was to test the "timelessness" of VAS responses. METHODS Face-to-face interviews were conducted in a convenience sample of healthy volunteers (n = 59) aged 20 to 63. Individuals rated their preferences for three health states of varying post chemotherapy nausea and vomiting (PCNV) severity and current health, assuming six different time horizons. Repeated measures analysis of variance (RM-ANOVA) was conducted (SX6X4X2) to determine the affect of time (6 levels:3 days, 3 months, 1-, 5-and 20-year(s) and rest of life), health state (4 levels: mild, moderate and severe PCNV and current health), and method (2 levels: SG and VAS) on preference. RESULTS Results were analyzed using RM-ANOVA and latent growth modeling (LGM). Both showed that preferences decreased over time for SG and VAS (p < 0.05). For the RM-ANOVA, all main effects and interaction terms were significant (p < 0.05).
LGM showed acceptable fit and significant slope parameters for all PCNV. The slopes were decreasing over time. Significant latent variances for LGM showed that not all individuals change at the same rate over time (p < 0.05) CONCLUSIONS There is a clear advantage in the use of LGM over RM-ANOVA because LGM can evaluate group differences in addition to individual changes over time. For the majority of respondents the utility independence assumption for SG and VAS did not hold both at the group and the individual level. Similar to Bala et al (1999) and Franic et al (2003) the results of this study indicated preferences as measured by SG and VAS are not timeless. Regardless of the preference measure used: both SG and VAS yield higher preferences for shorter time horizons. codes, and number of unique drug molecules) measured over a 1-year baseline period were compared in 7 conditions (acute coronary syndrome, sample N = 14,951; rheumatoid arthritis [RA] , N = 27,085; depression, N = 129,206; diabetes, N = 126,087; hypertension, N = 225,080; asthma, N = 56,172; fibromyalgia, N = 52,365) on the basis of 3 outcomes (total health care cost, emergency room [ER] visits, inpatient admissions) measured over a 1-year follow-up period. Goodness-of-fit statistics (chi-squared statistic for total health care costs and c-statistic for ER visits and inpatient admissions) were compared across age and sex-adjusted regression models for each individual RAM. RESULTS: A unique 3-digit ICD-9-CM code count that excluded 'rule-out' diagnoses consistently outperformed, i.e., had highest chisquared and c-statistics, every other RAM in every condition and outcome with the exception of the number of unique NDC codes, which performed the best for all outcomes in depression and fibromyalgia patients. The number of unique NDC codes was generally the second-best performing RAM across all outcomes. The CDS performed worst across every condition and outcome. CONCLUSIONS: Complex RAMs are subject to inconsistencies in their operationalization and application from a programming perspective. Across multiple acute and chronic conditions, the two simplest and programmatically-transparent RAMs were the most predictive measures of total health care cost, ER visits, and inpatient admissions.
PODIUM SESSION I: RISK MANAGEMENT STUDIES

RM1 COMPARATIVE PERFORMANCE OF RISK ADJUSTMENT MEASURES IN A SAMPLE OF COMMERCIALLY-INSURED PATIENTS UNDER AGE 65-TWO SIMPLE MEASURES OUTPERFORM CURRENT STANDARDS
RM2 IMPACT OF ADHERENCE WITH STATIN THERAPY ON HOSPITALIZATION RISK AND MORTALITY AMONG PATIENTS WITH DIABETES
Yang Y, Banahan BF, Pace PF University of Mississippi, University, MS, USA OBJECTIVES: The objective of this study was to evaluate the impact of adherence with statin therapy on diabetes-specific hospitalization and all-cause mortality among patients with diabetes enrolled in a state Medicaid program. METHODS: The authors conducted a retrospective cohort study of patients with diabetes who were continuously enrolled in a state Medicaid program from January 2002 to December 2004. The date of the first medication claim for statin during the first six months of 2002 was the index date. Adherence to statin was assessed within one year following the index date. Adherence was assessed using the proportion of days covered (PDC) and patients with a PDC of 0.8 or greater considered being adherent. The primary outcomes of interest were diabetes-specific hospitalization and all-cause mortality during the follow-up period (end of adherence measurement to December 31, 2004) . Multivariate regression analyses were performed to assess the impact of adherence with statin therapy on outcome measures. RESULTS: A total 10,839 patients were included in the study. Mean age 60.3 ± 10.0 years, 23.8% male, 76.2 female; 31.7% white, 50.4% black. At 12 months after the index prescription, only 23.9% of patients were adherent with their prescribed statin therapy. During follow-up After controlling for age, gender, race, prior hospitalization, and Charlson comorbidity index, patients who were adherent to statin therapy were 48.7% (OR: 0.513; 95%CI: 0.421-0.624) less likely to have diabetes-specific hospital admissions in comparison to nonadherent patients. Adherence with statin therapy had no statistically significant impact on allcause mortality (OR: 0.801; 95%CI: 0.454-1.412). CONCLUSIONS: Adherence with statin therapy was poor among patients with diabetes enrolled in a Medicaid program. Adherence with statin therapy was associated with significantly less risk for diabetes-specific hospitalization. Greater efforts are needed to facilitate diabetes selfmanagement behaviors to improve patient outcomes.
RM3 RISK OF FALLS AND FRACTURES IN OLDER ADULTS USING ATIPSYCHOTIC AGENTS-A PROPENSITY-MATCHED RETROSPECTIVE COHORT STUDY
Mehta S, Aparasu RR, Chen H, Johnson M University of Houston, Houston, TX, USA OBJECTIVES: To examine the risk of falls/fractures associated with atypical antipsychotic use compared to typical antipsychotic use in community dwelling older adults.
METHODS:
The population based retrospective cohort analysis based on propensity score matching was conducted using IMS LifeLink™ Health Plan claims data. Patients were included in the cohort if they met following criteria: ≥ 50 years of age, new users of atypical or conventional antipsychotics who began taking antipsychotics between July 2000 and December 2007, and continuously enrolled for six months before and at least six months after initiation of antipsychotic treatment. Patients taking atypical antipsychotics were matched with those using typical antipsychotics using propensity score greedy matching technique. Kaplan-Meier survival curves and Cox proportional hazard model stratified on matched pair was employed to examine risk of hospitalization/emergency visit due to falls or femur fractures within one year. Duration of antipsychotic therapy and exposure to other psychotropic medications were controlled for in the final model. RESULTS: A total of 11,160 older adults (5,580 atypical and 5,580 typical users) were identified as new users of antipsychotics after matching. Within one year of follow up period, 456 patients (8.06 %) in atypical drug group had falls/femur fractures compared to 375 (6.72%) in typical antipsychotic group. No significant difference was found between atypical users compared to typical agents with respect to risk of falls/fractures [Hazard Ration (HR) 1.01, 95% CI 0.83-1.22]. However, duration of therapy more than 90 days was significantly (HR, 1.81, CI, 1.35-2.43) associated with increased risk of falls/fractures compared to less than 30 days. CONCLUSIONS: The study results show no significant difference in the risk of falls/fractures between atypical and typical antipsychotic use among older adults. However, there is a need to be cautious while prescribing atypical and typical antipsychotics in older adults for longer periods of time.
